Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 27-Feb-24 5:12 PM View:  | Duraibabu Prathyusha SVP, Chief Financial Officer | Sangamo Biosciences Inc. (SGMO) | 25-Feb-24 | Payment of Exercise | 3,453 | $1.13 | $3,901.89 | (< 1%) 838.03K to 834.58K | |
| 27-Feb-24 5:13 PM View: | Willoughby Scott B. SVP, Gen. Counsel & Secretary | Sangamo Biosciences Inc. (SGMO) | 25-Feb-24 | Payment of Exercise | 3,453 | $1.13 | $3,901.89 | (< 1%) 839.88K to 836.43K | |
| 27-Feb-24 5:14 PM View: | Pooler Amy VP, Head of Research | Sangamo Biosciences Inc. (SGMO) | 25-Feb-24 | Payment of Exercise | 2,459 | $1.13 | $2,778.67 | (1%) 198.77K to 196.31K | |
| 27-Feb-24 5:11 PM View: | MacRae Sandy President, CEO and Director Director | Sangamo Biosciences Inc. (SGMO) | 25-Feb-24 | Payment of Exercise | 24,157 | $1.13 | $27,297.40 | (< 1%) 2.58M to 2.55M | |
| 27-Feb-24 5:13 PM View: | Dubois-Stringfellow Nathalie SVP-Chief Development Officer | Sangamo Biosciences Inc. (SGMO) | 25-Feb-24 | Payment of Exercise | 5,010 | $1.13 | $5,661.30 | (< 1%) 851.2K to 846.19K | |
| 27-Feb-24 5:13 PM View: | Willoughby Scott B. SVP, Gen. Counsel & Secretary | Sangamo Biosciences Inc. (SGMO) | 24-Feb-24 | Payment of Exercise | 4,379 | $1.13 | $4,948.27 | (< 1%) 844.26K to 839.88K | |
| 27-Feb-24 5:14 PM View: | Pooler Amy VP, Head of Research | Sangamo Biosciences Inc. (SGMO) | 24-Feb-24 | Payment of Exercise | 2,209 | $1.13 | $2,496.17 | (1%) 200.98K to 198.77K | |
| 27-Feb-24 5:11 PM View: | MacRae Sandy President, CEO and Director Director | Sangamo Biosciences Inc. (SGMO) | 24-Feb-24 | Payment of Exercise | 16,115 | $1.13 | $18,209.90 | (< 1%) 2.59M to 2.58M | |
| 27-Feb-24 5:13 PM View: | Dubois-Stringfellow Nathalie SVP-Chief Development Officer | Sangamo Biosciences Inc. (SGMO) | 24-Feb-24 | Payment of Exercise | 5,474 | $1.13 | $6,185.62 | (< 1%) 856.67K to 851.2K | |
| 27-Feb-24 5:12 PM View: | Duraibabu Prathyusha SVP, Chief Financial Officer | Sangamo Biosciences Inc. (SGMO) | 24-Feb-24 | Payment of Exercise | 5,474 | $1.13 | $6,185.62 | (< 1%) 843.5K to 838.03K | |
| 24-Jan-24 4:41 PM View: | Duraibabu Prathyusha SVP, Chief Financial Officer | Sangamo Biosciences Inc. (SGMO) | 22-Jan-24 | Grant | 712,500 | -- | -- | 544% 131.0K to 843.5K | |
| 24-Jan-24 4:42 PM View: | Willoughby Scott B. SVP, Gen. Counsel & Secretary | Sangamo Biosciences Inc. (SGMO) | 22-Jan-24 | Grant | 712,500 | -- | -- | 541% 131.76K to 844.26K | |
| 24-Jan-24 4:42 PM View: | Pooler Amy VP, Head of Research | Sangamo Biosciences Inc. (SGMO) | 22-Jan-24 | Grant | 150,000 | -- | -- | 294% 50.98K to 200.98K | |
| 24-Jan-24 4:39 PM View: | MacRae Sandy President, CEO and Director Director | Sangamo Biosciences Inc. (SGMO) | 22-Jan-24 | Grant | 2,000,000 | -- | -- | 338% 592.48K to 2.59M | |
| 24-Jan-24 4:40 PM View: | Dubois-Stringfellow Nathalie SVP-Chief Development Officer | Sangamo Biosciences Inc. (SGMO) | 22-Jan-24 | Grant | 712,500 | -- | -- | 494% 144.17K to 856.67K | |
| 28-Nov-23 4:18 PM View: | Fontenot Jason D. SVP, Chief Scientific Officer | Sangamo Biosciences Inc. (SGMO) | 25-Nov-23 | Payment of Exercise | 1,030 | $0.38 | $393.56 | (< 1%) 137.3K to 136.27K | |
| 28-Nov-23 4:15 PM View: | Pooler Amy VP, Head of Research | Sangamo Biosciences Inc. (SGMO) | 25-Nov-23 | Payment of Exercise | 490 | $0.38 | $187.23 | (< 1%) 51.47K to 50.98K | |
| 28-Nov-23 4:19 PM View: | McClung David Mark EVP, Chief Operating Officer | Sangamo Biosciences Inc. (SGMO) | 25-Nov-23 | Payment of Exercise | 1,925 | $0.38 | $735.54 | (< 1%) 214.4K to 212.47K | |
| 28-Nov-23 4:19 PM View: | MacRae Sandy President, CEO and Director Director | Sangamo Biosciences Inc. (SGMO) | 25-Nov-23 | Payment of Exercise | 10,411 | $0.38 | $3,978.04 | (2%) 602.89K to 592.48K | |
| 28-Nov-23 4:16 PM View: | Dubois-Stringfellow Nathalie SVP-Chief Development Officer | Sangamo Biosciences Inc. (SGMO) | 25-Nov-23 | Payment of Exercise | 1,462 | $0.38 | $558.63 | (1%) 140.63K to 139.17K | |
| 28-Nov-23 4:17 PM View: | Duraibabu Prathyusha SVP, Chief Financial Officer | Sangamo Biosciences Inc. (SGMO) | 25-Nov-23 | Payment of Exercise | 1,329 | $0.38 | $507.81 | (1%) 132.33K to 131.0K | |
| 28-Nov-23 4:20 PM View: | Willoughby Scott B. SVP, Gen. Counsel & Secretary | Sangamo Biosciences Inc. (SGMO) | 25-Nov-23 | Payment of Exercise | 1,329 | $0.38 | $507.81 | (1%) 128.09K to 126.76K | |
| 28-Sep-23 5:30 PM View: | Biogen Idec Inc 10% Owner | Sangamo Biosciences Inc. (SGMO) | 26-Sep-23 | Sale | 6,000,000 | $0.50 | $3,000,000.00 | (25%) 23.65M to 17.65M | |
| 29-Aug-23 4:12 PM View: | Willoughby Scott B. SVP, Gen. Counsel & Secretary | Sangamo Biosciences Inc. (SGMO) | 25-Aug-23 | Payment of Exercise | 1,329 | $0.77 | $1,023.33 | (1%) 129.42K to 128.09K | |
| 29-Aug-23 4:13 PM View: | MacRae Sandy President, CEO and Director Director | Sangamo Biosciences Inc. (SGMO) | 25-Aug-23 | Payment of Exercise | 10,411 | $0.77 | $8,016.47 | (2%) 613.3K to 602.89K | |
| 29-Aug-23 4:13 PM View: | Dubois-Stringfellow Nathalie SVP-Chief Development Officer | Sangamo Biosciences Inc. (SGMO) | 25-Aug-23 | Payment of Exercise | 1,462 | $0.77 | $1,125.74 | (1%) 142.1K to 140.63K | |
| 29-Aug-23 4:15 PM View: | Fontenot Jason D. SVP, Chief Scientific Officer | Sangamo Biosciences Inc. (SGMO) | 25-Aug-23 | Payment of Exercise | 1,029 | $0.77 | $792.33 | (< 1%) 138.33K to 137.3K | |
| 29-Aug-23 4:15 PM View: | McClung David Mark EVP, Chief Operating Officer | Sangamo Biosciences Inc. (SGMO) | 25-Aug-23 | Payment of Exercise | 1,925 | $0.77 | $1,482.25 | (< 1%) 216.32K to 214.4K | |
| 29-Aug-23 4:14 PM View: | Duraibabu Prathyusha SVP, Chief Financial Officer | Sangamo Biosciences Inc. (SGMO) | 25-Aug-23 | Payment of Exercise | 1,329 | $0.77 | $1,023.33 | (< 1%) 133.66K to 132.33K | |
| 15-Aug-23 4:55 PM View: | Willoughby Scott B. SVP, Gen. Counsel & Secretary | Sangamo Biosciences Inc. (SGMO) | 13-Aug-23 | Payment of Exercise | 864 | $1.08 | $933.12 | (< 1%) 130.28K to 129.42K | |
| 26-Jun-23 4:31 PM View: | McClung David Mark EVP, Chief Operating Officer | Sangamo Biosciences Inc. (SGMO) | 25-Jun-23 | Payment of Exercise | 11,528 | $1.19 | $13,718.30 | (5%) 222.85K to 211.32K | |
| 13-Jun-23 4:55 PM View: | Duraibabu Prathyusha SVP, Chief Financial Officer | Sangamo Biosciences Inc. (SGMO) | 11-Jun-23 | Payment of Exercise | 864 | $1.19 | $1,028.16 | (< 1%) 134.53K to 133.66K | |
| 05-Jun-23 4:51 PM View: | Parker H Stewart Director | Sangamo Biosciences Inc. (SGMO) | 01-Jun-23 | Grant | 13,900 | -- | -- | 29% 48.7K to 62.6K | |
| 05-Jun-23 4:48 PM View: | Hillan Kenneth Director | Sangamo Biosciences Inc. (SGMO) | 01-Jun-23 | Grant | 13,900 | -- | -- | 39% 35.7K to 49.6K | |
| 05-Jun-23 4:49 PM View: | Markels John Director | Sangamo Biosciences Inc. (SGMO) | 01-Jun-23 | Grant | 13,900 | -- | -- | 43% 32.48K to 46.38K | |
| 05-Jun-23 4:46 PM View: | Beers Courtney Director | Sangamo Biosciences Inc. (SGMO) | 01-Jun-23 | Grant | 13,900 | -- | -- | 74% 18.75K to 32.65K | |
| 05-Jun-23 4:47 PM View: | Carey Robert Director | Sangamo Biosciences Inc. (SGMO) | 01-Jun-23 | Grant | 13,900 | -- | -- | 39% 35.7K to 49.6K | |
| 05-Jun-23 4:52 PM View: | Smith Karen L. Director | Sangamo Biosciences Inc. (SGMO) | 01-Jun-23 | Grant | 13,900 | -- | -- | 36% 38.2K to 52.1K | |
| 05-Jun-23 4:50 PM View: | Meyers James R Director | Sangamo Biosciences Inc. (SGMO) | 01-Jun-23 | Grant | 13,900 | -- | -- | 39% 35.7K to 49.6K | |
| 05-Jun-23 4:48 PM View: | Horn Margaret A Director | Sangamo Biosciences Inc. (SGMO) | 01-Jun-23 | Grant | 13,900 | -- | -- | 74% 18.75K to 32.65K | |
| 30-May-23 4:43 PM View: | McClung David Mark EVP, Chief Operating Officer | Sangamo Biosciences Inc. (SGMO) | 25-May-23 | Payment of Exercise | 1,925 | $1.33 | $2,560.25 | (< 1%) 224.77K to 222.85K | |
| 30-May-23 4:41 PM View: | Duraibabu Prathyusha SVP, Chief Financial Officer | Sangamo Biosciences Inc. (SGMO) | 25-May-23 | Payment of Exercise | 1,328 | $1.33 | $1,766.24 | (< 1%) 133.38K to 132.05K | |
| 30-May-23 4:40 PM View: | MacRae Sandy President, CEO and Director Director | Sangamo Biosciences Inc. (SGMO) | 25-May-23 | Payment of Exercise | 10,411 | $1.33 | $13,846.60 | (2%) 623.71K to 613.3K | |
| 30-May-23 4:43 PM View: | Dubois-Stringfellow Nathalie SVP-Chief Development Officer | Sangamo Biosciences Inc. (SGMO) | 25-May-23 | Payment of Exercise | 1,462 | $1.33 | $1,944.46 | (1%) 138.56K to 137.1K | |
| 30-May-23 4:42 PM View: | Fontenot Jason D. SVP, Chief Scientific Officer | Sangamo Biosciences Inc. (SGMO) | 25-May-23 | Payment of Exercise | 1,029 | $1.33 | $1,368.57 | (< 1%) 139.36K to 138.33K | |
| 30-May-23 4:45 PM View: | Willoughby Scott B. SVP, Gen. Counsel & Secretary | Sangamo Biosciences Inc. (SGMO) | 25-May-23 | Payment of Exercise | 1,328 | $1.33 | $1,766.24 | (1%) 126.61K to 125.28K | |
| 30-May-23 4:44 PM View: | Ramelmeier Rolf Andrew EVP, Technical Operations | Sangamo Biosciences Inc. (SGMO) | 25-May-23 | Payment of Exercise | 1,750 | $1.33 | $2,327.50 | (1%) 173.22K to 171.47K | |
| 26-Apr-23 5:22 PM View: | Willoughby Scott B. SVP, Gen. Counsel & Secretary | Sangamo Biosciences Inc. (SGMO) | 24-Apr-23 | Payment of Exercise | 3,977 | $1.65 | $6,562.05 | (3%) 130.59K to 126.61K | |
| 28-Mar-23 5:04 PM View: | Duraibabu Prathyusha SVP, Chief Financial Officer | Sangamo Biosciences Inc. (SGMO) | 25-Mar-23 | Payment of Exercise | 345 | $1.66 | $572.70 | (< 1%) 133.72K to 133.38K | |
| 06-Mar-23 5:09 PM View: | Ramelmeier Rolf Andrew EVP, Technical Operations | Sangamo Biosciences Inc. (SGMO) | 25-Feb-23 | Payment of Exercise | 15,618 | $2.66 | $41,543.90 | (8%) 188.84K to 173.22K |
